Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

2011 SVBVS Business Plan Competition Finalists (1 of 2)

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
248 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Aug 5, 2011

$10,000 FINALISTS

AfterSteps is an online end-of-life planning platform. It enables customers to create a plan, store it, and transfer it to designated beneficiaries. This provides users peace of mind and control, and reduces the stress and expenses for surviving loved ones.

Clear Ear is a cost-effective impacted ear wax removal technology platform for underserved global elderly population. Over 55% of the hearing aid users and seniors suffer from this condition and its clinical sequelae. Even in developed countries, syringing - the most commonly performed procedure (14 million procedures in the U.S. alone in 2010) - leads to 38% complication rate.

MEMStim is a fables semiconductor company that designs and sells electrode leads to medical device companies for use in neurostimulators. Our patented technology enables medical device companies to eliminate costly manual assembly processes while creating the next generation of neurological therapies.

For millions of baby boomers, severe dry eye disease is a cripplingly painful disease that threatens vision with no effective treatments in a $2 billion market. Oculeve's REVIVE is a therapy developed at Stanford University that restores natural tear production.

OMyMeds will be the "Mint.com" of medication reconciliation. By aggregating medication prescriptions automatically from pharmacy and insurance websites, coupled with patient interviews, the service will generate an updated, accurate medication list, with pill images, in an easy to understand format.

Pontus Medical is dedicated to improving the lives of heart failure patients by preventing rehospitalizations. Heart failure is the number one cause for hospitalization in adults over the age of 65. Our low-cost solution consists of wearable patches that predict exacerbation in these patients by non-invasively monitoring their fluid status and providing actionable information.

Quipu, biomedical company with patent technology from the Italian National Research Council, develops non-invasive systems for early and accurate diagnosis of cardiovascular risk.

Category:

Nonprofits & Activism

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more